Similar articles for PMID: 18535026

Year	Number of Results
1990	1
1993	2
1995	1
1996	1
2000	1
2003	1
2004	1
2005	3
2006	4
2007	5
2008	7
2009	9
2010	2
2011	6
2012	8
2013	8
2014	10
2015	15
2016	10
2017	4
2018	4
2019	5
2020	4
2021	3
2022	1
2023	1
2024	0

1

Relapses in multiple sclerosis are age- and time-dependent.

Tremlett H, Zhao Y, Joseph J, Devonshire V; UBCMS Clinic Neurologists. Tremlett H, et al. J Neurol Neurosurg Psychiatry. 2008 Dec;79(12):1368-74. doi: 10.1136/jnnp.2008.145805. Epub 2008 Jun 5. J Neurol Neurosurg Psychiatry. 2008. PMID: 18535026

2

Increased relapse rate in pediatric-onset compared with adult-onset multiple sclerosis.

Gorman MP, Healy BC, Polgar-Turcsanyi M, Chitnis T. Gorman MP, et al. Arch Neurol. 2009 Jan;66(1):54-9. doi: 10.1001/archneurol.2008.505. Arch Neurol. 2009. PMID: 19139299

3

Early relapses, onset of progression, and late outcome in multiple sclerosis.

Scalfari A, Neuhaus A, Daumer M, Deluca GC, Muraro PA, Ebers GC. Scalfari A, et al. JAMA Neurol. 2013 Feb;70(2):214-22. doi: 10.1001/jamaneurol.2013.599. JAMA Neurol. 2013. PMID: 23407713

4

The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.

Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, Ebers GC. Scalfari A, et al. Brain. 2010 Jul;133(Pt 7):1914-29. doi: 10.1093/brain/awq118. Epub 2010 Jun 9. Brain. 2010. PMID: 20534650 Free PMC article.

5

Predictive value of clinical characteristics for 'benign' multiple sclerosis.

Ramsaransing GS, De Keyser J. Ramsaransing GS, et al. Eur J Neurol. 2007 Aug;14(8):885-9. doi: 10.1111/j.1468-1331.2007.01810.x. Eur J Neurol. 2007. PMID: 17662009

6

Predictors of relapse rate in MS clinical trials.

Held U, Heigenhauser L, Shang C, Kappos L, Polman C; Sylvia Lawry Centre for MS Research. Held U, et al. Neurology. 2005 Dec 13;65(11):1769-73. doi: 10.1212/01.wnl.0000187122.71735.1f. Neurology. 2005. PMID: 16344520

7

Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.

Alroughani RA, Akhtar S, Ahmed SF, Al-Hashel JY. Alroughani RA, et al. Int J Neurosci. 2015;125(11):831-7. doi: 10.3109/00207454.2014.976641. Epub 2014 Nov 11. Int J Neurosci. 2015. PMID: 25329929

8

Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis.

Novotna M, Paz Soldán MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH. Novotna M, et al. Neurology. 2015 Aug 25;85(8):722-9. doi: 10.1212/WNL.0000000000001856. Epub 2015 Jul 24. Neurology. 2015. PMID: 26208962 Free PMC article.

9

Using observational analysis of multiple sclerosis relapse to design outcomes-based contracts for disease-modifying drugs: a feasibility assessment.

Lage MJ, Carroll CA, Fairman KA. Lage MJ, et al. J Med Econ. 2013 Sep;16(9):1146-53. doi: 10.3111/13696998.2013.823868. Epub 2013 Aug 8. J Med Econ. 2013. PMID: 23844620 Free article.

10

Predictors of long-term interferon discontinuation in newly diagnosed relapsing multiple sclerosis.

Moccia M, Palladino R, Carotenuto A, Russo CV, Triassi M, Lanzillo R, Brescia Morra V. Moccia M, et al. Mult Scler Relat Disord. 2016 Nov;10:90-96. doi: 10.1016/j.msard.2016.09.011. Epub 2016 Sep 28. Mult Scler Relat Disord. 2016. PMID: 27919507

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year